Proteomic profiling identifies novel proteins for genetic risk of severe COVID-19: the Atherosclerosis Risk in Communities Study.
Brian T SteffenJames S PankowPamela L LutseyRyan T DemmerJeffrey R MisialekWeihua GuanLogan T CowanJosef CoreshFaye L NorbyWeihong TangPublished in: Human molecular genetics (2022)
Novel proteomics signatures and pathways for COVID-19-related risk variants TYK2 and ABO were identified. A subset of these proteins predicted greater risk of incident hospitalized pneumonia and respiratory infections. Further studies to examine these proteins in COVID-19 patients are warranted.